The Changing Landscape for Stroke Prevention in AF
Article 2017 en
Authors
MH
Menno V. Huisman
KR
Kenneth J. Rothman
MP
Miney Paquette
Abstract
1 min read
The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701).
Christine Teutsch, Menno V. Huisman, Professor Gregory Lip, Hans‐Christoph Diener, Sérgio Dubner, Changsheng Ma, Kenneth J. Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Dorothee B. Bartels, Jonathan L. Halperin
Yang Liu, Steven Ho Man Lam, Giulio Francesco Romiti, Bi Huang, Yang Chen, Tze-Fan Chao, Brian Olshansky, Kui Hong, Menno V. Huisman, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.